This three-year randomized controlled trial, involved 300 HIV-positive patients, who had not begun antiretroviral therapy (ART). The results showed a 48 per cent decrease in the rate of CD4 decline. CD4 cells are a type of white blood cell that plays a crucial role in protecting the body from infection. The HIV virus attacks and destroys the CD4 cells of a person’s immune system. CD4 counts are a strong indicator of the progression of the disease. A low CD4 count is one of the ways to tell if a person living with HIV has progressed to stage 3 infection (AIDS). Funded by Global Benefit Canada, now IBG, the study was conducted by medical professionals in Rwanda, and supported by Canadians Dr. Don Warren, ND. Dr. Ed Mills and Dr. Dugald Seely.
Selenium is an essential trace mineral known for its antioxidant properties and for its role in preserving immune competency. The main source of selenium in the body comes from food; the amount of selenium in food depends on where the food is grown or raised. The level of selenium in soils varies significantly around the world. Dr. Harold Foster, a medical geographer, theorized that the reason AIDS was so prevalent in East and South Africa was because of the low levels of selenium in the soil. The study shows that selenium supplementation may be a positive way to slow the progression of the disease in HIV positive persons.